Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts. Issue 7 (29th April 2019) - Strati, Paolo; Garcia‐Manero, Guillermo; Zhao, Chong; Kadia, Tapan; Borthakur, Gautam; Konopleva, Marina; Daver, Naval; DiNardo, Courtney D.; Short, Nicholas J.; Yilmaz, Musa; Naqvi, Kiran; Alvarado, Yesid; et al.